Qualidade de vida dos demandantes de medicamentos oncológicos nas vias administrativa e judicial em Goiás
Nenhuma Miniatura disponível
Data
2022-10-16
Autores
Título da Revista
ISSN da Revista
Título de Volume
Editor
Universidade Federal de Goiás
Resumo
Background: The significant increase in access to oncological medicines through court cases suggests that constitutional guarantees of integral and universal care in the Brazilian public health system are uncertain.
Methods: A retrospective observational study was conducted to analyze data from lawsuits requesting oncological medicines from 2014 to 2020 in the State of Goiás, Brazil, in state and federal courts. Sociodemographic, medical, and legal variables were statistically examined using descriptive, association, and correlation methods.
Results: Women brought more than half (54%) of the 301 processes analyzed. The most frequent age group was over 55 years, with income below 3x the minimum wage (total about USD$600/month), and their cases were promoted through the public minister and public defender’s offices. The most requested medications, not on official public health system lists, were indicated for multiple myeloma and brain cancer.
Conclusions: Improved quality of life, frequently used as a justification, could be conceptually confused with an increase in survival. Finally, judicialization indicates that individual health needs arise even with properly defined and adequately implemented public policies. These needs should be considered for the adequate provisioning of services by the state to ensure the right to health.
Descrição
Citação
SALHA, L. A. Qualidade de vida dos demandantes de medicamentos oncológicos nas vias administrativa e judicial em Goiás. 2022. 242 f. Tese (Doutorado em Ciências Saúde) - Faculdade de Medicina, Universidade Federal de Goiás, Goiânia, 2022.